SEC 13F Intelligence

Almitas Capital LLC / ANTX

Almitas Capital LLC’s An2 Therapeutics Inc Position

Does Almitas Capital LLC own An2 Therapeutics Inc (ANTX)? Yes — 1.48M shares worth $5M (+1.14% of its 13F portfolio) as of Q1 2026.

Position Value
$5M
Q1 2026
Shares
1.48M
% of Portfolio
+1.14%
Quarters Held
6
currently held

Position History ANTX

Reported value by quarter
Q4 ’24: $2MQ4 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.48M$5M+1.14%
Q4 20251.48M$2M+0.37%
Q3 20252.86M$4M+0.42%
Q2 20251.43M$2M+0.38%
Q1 20251.31M$2M+0.59%
Q4 20241.31M$2M+0.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Almitas Capital LLC’s full portfolio or all institutional holders of ANTX.